:::

詳目顯示

回上一頁
題名:從歐洲專利公約及美國專利法的規定談醫療方法發明及用途發明
書刊名:智慧財產權月刊
作者:董安丹
作者(外文):Dong, Ann D.
出版日期:2004
卷期:61
頁次:頁54-83
主題關鍵詞:歐洲專利公約美國專利法醫療方法發明醫療用途發明
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(2) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:2
  • 共同引用共同引用:6
  • 點閱點閱:3
期刊論文
1.董安丹(20020300)。美國專利法上非顯著性之判斷--化學發明非顯著性之研究。智慧財產權月刊,39,36-72。new window  延伸查詢new window
2.Blodgett, Gerry Alan(1981)。Relative Significance: A Concept in Chemical Structural Obviousness Cases。J. Pat. Off. Soc'y.,63,70。  new window
3.Portman, Robert M.(1996)。Legislative Restriction on Removes Medical and Surgical Procedure Patents Impediment to Medical Progress。U. Balt. Intell. Prop. J.,4,99。  new window
4.Ho, Cynthia M.(2000)。Patents, Patients, and Public Policy: An Incomplete. Intersection at 35 U.S.C. 287 (c)。U. C. Davis. Rev.,33,601-635。  new window
5.Klopscch, Geraldc(1982)。The Patentability of Pharmaceuticals According to the European Patent Convention (EPC)。IIC,13(4),458。  new window
6.Stieger, Werner(1982)。Article 54(5) of the Munich Patent Convention : An Exception for Pharmaceuticals。ICC,13,139。  new window
7.Utermann, Jasper(1986)。Purpose-Bound Process Claim for Pharmaceuticals-Two Solutions for the Second Indication。IIC,17,44。  new window
8.Benyamini, Amiram(1993)。Patent Infringement in the European Community。IIC,13,92-93。  new window
9.Perron, Jean M.(1985)。Patentability of a Second Indication of a Pharmaceutical in Europe。Idea--The Journal of Law and Technology,26,15。  new window
10.Marquis, Harold L.(1981)。Economic Analysis of the Patentability of Chemical Compounds。J. P. O. S.,63,3。  new window
11.Konkol, Chris P.(1990)。A Critique of the Concept of Relative Significance in Determining Obviousness。Idea--The Journal of Law and Technology,31,228。  new window
12.(1974)。Standards of Obviousness and the Patentability of Chemical Compounds。Harvard Law Review,87,618。  new window
13.董安丹(20020400)。美國專利法上非顯著性之判斷--化學發明非顯著性之研究。智慧財產權月刊,40,33-54。new window  延伸查詢new window
14.董安丹(19990700)。美國專利法上之非顯著性:歷史發展及GRAHAM原則。智慧財產權月刊,7,頁80-87。new window  延伸查詢new window
15.董安丹(19990900)。美國專利法上之非顯著性:歷史發展及GRAHAM原則。智慧財產權月刊,9,頁66-74。new window  延伸查詢new window
16.董安丹(19991200)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,12,頁71-81。new window  延伸查詢new window
17.董安丹(19991000)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,10,頁69-82。new window  延伸查詢new window
18.董安丹(19991100)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,11,頁12-21。new window  延伸查詢new window
19.Moufang, Rainer(1993)。Methods of Medical Treatment Under Patent Law。IIC,24(1),18-49。  new window
圖書
1.Grubb, Philip W.(1999)。Patents for Chemicals, Pharmaceuticals and Biotechnology: Fundamentals of Global Law Practice and Strategy。  new window
2.Goldbach, K.、Vogelsang-Wenke, H.、Zimmer, F.-J.(1997)。Protection of Biotechnological Matter under European and German Law。VCH-Law Books。  new window
3.Faber, Robert C.(1999)。Landis on Mechanics of Patent Claim Drafting。Practising Law Institute。  new window
其他
1.Method of making self-sealing episcleral incision(US 5,080,111)。  new window
2.Clarkson, Eric Potter。Recent Decision of the English High Court Concerning New Use Claims,http://www.eric-potter.com。  new window
3.Bennett, Virginia C.。Limitations on Patents Claiming Medical or Surgical Procedures,http://www.myersbigel.com/pat_articles/pat_article3.htm。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top